MedVellum
MedVellum
Back to Library

Migraine Headache

On This Page

Overview

Migraine Headache

Quick Reference

Critical Alerts

  • Rule out secondary causes first: Thunderclap headache, worst headache of life, fever, focal deficits
  • Triptans are first-line abortive therapy: If no contraindications
  • IV fluids + IV antiemetic + IV NSAID = Effective ED cocktail
  • Status migrainosus needs aggressive treatment: Lasting >72 hours
  • Avoid opioids: Not first-line; risk of medication overuse headache
  • Triptans contraindicated in CAD, uncontrolled HTN, prior stroke

Red Flags (SNOOP4)

LetterRed Flag
SSystemic symptoms (fever, weight loss) or Systemic illness (cancer, HIV)
NNeurological signs (focal deficits, papilledema, altered consciousness)
OOnset sudden (thunderclap)
OOlder age (new headache >0 years)
PPattern change (worsening, different character)
PPrecipitated by Valsalva, exertion, position
PPapilledema
PPregnancy or postpartum

Emergency Treatments

TreatmentDoseNotes
IV fluidsNS 500-1000 mLRehydration
Metoclopramide10-20 mg IVAntiemetic + analgesic properties
Prochlorperazine10 mg IVAntiemetic; can cause akathisia
Ketorolac15-30 mg IVNSAID
Sumatriptan6 mg SC or 100 mg POIf no contraindications
Dexamethasone10 mg IVReduces recurrence
Diphenhydramine25-50 mg IVFor akathisia prevention with metoclopramide

Definition

Overview

Migraine is a primary headache disorder characterized by recurrent, moderate-to-severe headaches often associated with nausea, vomiting, photophobia, and phonophobia. Some migraines are preceded by aura. ED management focuses on ruling out secondary causes, providing abortive therapy, and reducing recurrence.

Classification

By Aura:

TypeFeatures
Migraine without auraMost common (70-80%)
Migraine with auraVisual, sensory, or language symptoms precede headache

Other Types:

TypeFeatures
Chronic migraine≥15 headache days/month for ≥3 months
Status migrainosusMigraine >2 hours
Hemiplegic migraineAura includes motor weakness
Menstrual migraineOccurs with menstruation

Epidemiology

  • Prevalence: 12% of adults (18% women, 6% men)
  • Peak age: 25-55 years
  • Female predominance: 3:1
  • Leading cause of years lost to disability in young women

Etiology

Triggers:

CategoryExamples
HormonalMenstruation, oral contraceptives
DietaryAlcohol (esp. red wine), caffeine, chocolate, aged cheeses, MSG
SleepToo little or too much sleep
StressEmotional or physical
EnvironmentalBright lights, loud sounds, strong odors, weather changes
MedicationsVasodilators, hormones

Pathophysiology

Mechanism

  1. Cortical spreading depression (in aura): Wave of neuronal depolarization
  2. Trigeminovascular activation: Trigeminal nerve releases CGRP, substance P
  3. Neurogenic inflammation: Vasodilation of meningeal vessels
  4. Central sensitization: Amplifies pain signals

Aura

  • Visual (scintillating scotoma, fortification spectra) most common
  • Sensory (paresthesias), language (aphasia), motor (hemiplegic)
  • Typically precedes headache by 5-60 minutes

Clinical Presentation

Symptoms

Headache Features (POUND):

LetterFeature
PPulsating quality
OOne-day duration (4-72 hours)
UUnilateral location
NNausea/vomiting
DDisabling intensity

Associated Symptoms:

History

Key Questions:

Physical Examination

General:

Neurological Exam:

In Classic Migraine:


Photophobia (light sensitivity)
Common presentation.
Phonophobia (sound sensitivity)
Common presentation.
Osmophobia (smell sensitivity)
Common presentation.
Visual aura (scintillating scotoma)
Common presentation.
Red Flags

Secondary Headache Warning Signs (SNOOP4)

FindingConcernAction
Thunderclap onsetSAH, RCVSCT head, LP if CT negative
Fever + headacheMeningitisLP, antibiotics
Focal neurological deficitsStroke, mass lesionCT/MRI
PapilledemaIncreased ICPImaging, LP
New headache >0 yearsGCA, malignancyESR, imaging
Worst headache of lifeSAHCT, LP
Headache with exertionSAH, massImaging
Progressive patternSecondary causeImaging

Differential Diagnosis

Other Causes of Headache

DiagnosisFeatures
Tension-type headacheBilateral, pressing, mild-moderate, no nausea
Cluster headacheUnilateral, severe, periorbital, autonomic symptoms
SAHThunderclap, worst headache of life
MeningitisFever, neck stiffness, photophobia
Temporal arteritis (GCA)Age >0, scalp tenderness, jaw claudication, vision changes
Intracranial massProgressive, focal deficits, worse in morning
Idiopathic intracranial hypertensionPapilledema, obesity, young woman
Medication overuse headacheDaily headaches, analgesic overuse

Diagnostic Approach

Clinical Diagnosis

  • Migraine is a clinical diagnosis
  • Based on history and normal neurological exam
  • Imaging for red flags only

Imaging

Not Routinely Indicated for Typical Migraine

Indications for CT/MRI:

IndicationImaging
Thunderclap headacheCT head → LP if CT negative
Focal neurological deficitsCT or MRI
New headache >0 yearsCT or MRI
PapilledemaCT or MRI
Change in headache patternConsider imaging
ImmunocompromisedCT or MRI

Laboratory Studies

TestIndication
ESR, CRPGCA suspected (>0 years)
LPSAH (CT negative), meningitis
Pregnancy testWomen of childbearing age

Treatment

Principles

  1. Rule out secondary causes: Red flags → Imaging/LP
  2. Rehydration: IV fluids
  3. Antiemetics: Relieve nausea and have analgesic properties
  4. NSAIDs or triptans: Abortive therapy
  5. Steroids: Reduce recurrence
  6. Avoid opioids: Not first-line

ED Migraine Cocktail

Common Regimen:

ComponentDoseNotes
IV fluidsNS 500-1000 mLRehydration
Metoclopramide10-20 mg IVAntiemetic + analgesic
+ Diphenhydramine25-50 mg IVPrevents akathisia
OR Prochlorperazine10 mg IVAlternative antiemetic
Ketorolac15-30 mg IVNSAID
Dexamethasone10 mg IVReduces recurrence

If Refractory, Add Triptan:

AgentDose
Sumatriptan6 mg SC or 100 mg PO

Triptans

Mechanism: 5-HT1B/1D receptor agonists; vasoconstriction, reduce CGRP release

Options:

AgentRouteDose
SumatriptanPO50-100 mg
SumatriptanSC6 mg
SumatriptanNasal20 mg
RizatriptanPO10 mg
ZolmitriptanPO2.5-5 mg

Contraindications:

  • Coronary artery disease
  • Prior stroke or TIA
  • Uncontrolled hypertension
  • Basilar or hemiplegic migraine
  • Use of ergots within 24 hours

Status Migrainosus (>72 Hours)

TreatmentDose
IV fluidsAggressive rehydration
IV antiemeticsMetoclopramide, prochlorperazine
IV NSAIDsKetorolac
IV magnesium1-2 g IV
IV dexamethasone10 mg
Valproate IV500-1000 mg (if refractory)
Dihydroergotamine (DHE)1 mg IV (if no contraindications)

Rescue Therapy

For Refractory Cases:

AgentNotes
Magnesium sulfate1-2 g IV over 15-30 min
Valproate sodium500-1000 mg IV
Dihydroergotamine (DHE)0.5-1 mg IV; may repeat
Opioids (last resort)IV morphine or hydromorphone; risk of rebound

Disposition

Discharge Criteria

  • Pain controlled
  • Able to tolerate oral intake
  • No red flag symptoms
  • Neurological exam normal
  • Follow-up with PCP or neurology

Admission Criteria

  • Status migrainosus not responding to treatment
  • Intractable vomiting/dehydration
  • Serious secondary cause identified
  • Need for IV medications not available outpatient

Referral

IndicationReferral
Frequent migraines (>/month)Neurology for prophylaxis
Medication overuseHeadache specialist
Atypical featuresNeurology

Discharge Prescriptions

MedicationNotes
Triptan (e.g., sumatriptan)For abortive use at home
Antiemetic (e.g., ondansetron, metoclopramide)As needed
NSAIDNaproxen, ibuprofen for mild attacks
Dexamethasone packMay reduce recurrence

Patient Education

Condition Explanation

  • "Migraine is a neurological condition that causes severe headaches with other symptoms like nausea and light sensitivity."
  • "We can treat this attack and help prevent future ones."
  • "Identifying and avoiding triggers can help."

Home Care

  • Take medications early in a migraine attack
  • Rest in a dark, quiet room
  • Stay hydrated
  • Avoid known triggers
  • Do not overuse analgesics (risk of medication overuse headache)

Warning Signs to Return

  • Worst headache of your life
  • Sudden onset "thunderclap" headache
  • Fever with headache
  • Weakness, numbness, or vision changes
  • Headache not responding to usual treatment

Special Populations

Pregnancy

  • Avoid triptans, NSAIDs (especially 3rd trimester), ergots
  • Acetaminophen is safe
  • Metoclopramide is generally safe
  • Magnesium may be helpful
  • Consult OB for refractory cases

Elderly

  • Higher concern for secondary causes
  • Triptans: Caution with cardiovascular disease
  • Consider GCA in new headache >50 years

Medication Overuse Headache

  • Ask about frequency of analgesic use
  • Triptans, NSAIDs, opioids, and acetaminophen can all cause
  • Prophylaxis is key; consider detox

Quality Metrics

Performance Indicators

MetricTargetRationale
Red flag assessment documented100%Rule out secondary causes
Neurological exam documented100%Standard of care
IV antiemetic given>0%Effective treatment
Avoid opioids for migraine>0%Stewardship
Dexamethasone for recurrence prevention>0%Evidence-based

Documentation Requirements

  • Headache features (POUND)
  • Red flag assessment
  • Neurological exam findings
  • Medications given and response
  • Discharge instructions and follow-up

Key Clinical Pearls

Diagnostic Pearls

  • SNOOP4 for red flags: Rule out secondary causes
  • Migraine is a clinical diagnosis: Imaging only for red flags
  • Thunderclap = SAH until proven otherwise: CT → LP
  • New headache >50 = GCA, malignancy: Check ESR, imaging
  • Normal neuro exam expected in migraine
  • Medication overuse is common: Ask about analgesic frequency

Treatment Pearls

  • Antiemetics have analgesic properties: Metoclopramide, prochlorperazine
  • Diphenhydramine prevents akathisia: Give with metoclopramide
  • Triptans are first-line abortive: If no contraindications
  • Dexamethasone reduces recurrence: 10 mg IV
  • Avoid opioids: Not first-line; risk of rebound
  • IV fluids help: Dehydration is common
  • Magnesium for refractory cases: 1-2 g IV

Disposition Pearls

  • Most can be discharged: With abortive prescriptions
  • Neurology for frequent migraines: For prophylaxis discussion
  • Admit for status migrainosus refractory to ED treatment
  • Educate on triggers and early treatment

References
  1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
  2. Friedman BW, et al. Randomized trial of IV metoclopramide plus diphenhydramine for acute migraine. Neurology. 2017;89(21):2194-2197.
  3. Orr SL, et al. Canadian Headache Society guideline for migraine in adults. CMAJ. 2021;193(26):E1051-E1066.
  4. Marmura MJ, et al. The acute treatment of migraine in adults: The American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3-20.
  5. Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330.
  6. Colman I, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis. BMJ. 2008;336(7657):1359-1361.
  7. AAN Clinical Practice Guideline. Treatment of migraine in adults. 2019.
  8. UpToDate. Acute treatment of migraine in adults. 2024.

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines